Company / Operating Income per Share
Cogent Biosciences, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.59
FY2025
5-year range
-$2.66 / -$1.95
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#134 of 201
Health Care
What the data says
At $-2.59, Cogent Biosciences, Inc.'s operating income per share ranks #134 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 3 years of decline, reaching $-2.59.
Based on SEC 10-K filings.
-2.59 in FY2025.
Remained stable around $-2.59 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 201 in Health CareTop 67% of 201This company -$2.59 Sector average -$28.51
▼
+90.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 2.7% year-over-year.
- Ranks #134 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.59 | +2.7% |
| FY2024 | -$2.66 | -1.7% |
| FY2023 | -$2.61 | -3.8% |
| FY2022 | -$2.52 | -29.0% |
| FY2021 | -$1.95 | +73.7% |
| FY2020 | -$7.42 | -75.7% |
| FY2019 | -$4.22 | -192.0% |
| FY2018 | -$1.45 | +43.6% |
| FY2017 | -$2.57 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026